The EU has published its Action Plan to tackle Antimicrobial Resistance (AMR) – a growing threat that is responsible for 25,000 deaths and a loss of €1.5 billion in the EU every year.
The plan includes guidelines for doctors, nurses, pharmacists, hospital administrators and others who play a role in antimicrobial use to promote their prudent use in people. These guidelines complement infection prevention and control guidelines which may exist at national level. In addition, the plan foresees more than 75 actions built on three main pillars:
- making the EU a best-practice region
- boosting research, development and innovation
- shaping the global agenda
For more information on the Action Plan to tackle Antimicrobial Resistance on the ec.europa.eu website
Unhealthy diets and low physical activity contribute to many chronic diseases and disability; they are responsible for some 2 in 5 deaths worldwide and for about 30% of the global disease burden. Yet surprisingly little is known about the economic costs that these risk factors cause, both for health care and society more widely.
This study pulls together the evidence about the economic burden that can be linked to unhealthy diets and low physical activity.
The study’s findings are a step towards a better understanding of the economic burden that can be associated with two key risk factors for ill health and they will help policymakers in setting priorities and to more effectively promoting healthy diets and physical activity.
To download the report Assessing the costs of unhealthy diet and low physical activity from the euro.who.int websit
1 in 5 children in high-income countries lives in relative income poverty and an average of 1 in 8 faces food insecurity, according to the latest report by the UNICEF Office of Research.
This report ‘Building the Future: children and the sustainable development goals in rich countries’ is the first report to assess the status of children in 41 high-income countries in relation to the Sustainable Development Goals (SDGs) identified as most important for child well-being. It ranks countries based on their performance and details the challenges and opportunities that advanced economies face in achieving global commitments to children.
To download the report on the status of children in high-income countries from the unicef-irc.org website
Each year, at least 1.4 million Europeans die prematurely due to polluted environments; this corresponds to at least 15% of Europe’s total deaths. Around half of these deaths are due to outdoor and indoor air pollution. Altogether, European citizens lose annually 50 million years of healthy life from environmental risks.
Environmental risk factors are responsible for around 26% of ischemic heart disease, 25% of strokes and 17% of cancers in Europe. Air pollution is the leading environmental killer, responsible for 620,000 deaths every year from outdoor (transport, industry, energy production) and indoor (solid fuel combustion for heating and cooking, poor ventilation, second-hand tobacco smoke) exposure.
For more information about the risks to public health of air pollution on the euro.who.int website
Between June 2016 and May 2017, an unusual increase in cases of hepatitis A affecting mainly men who have sex with men (MSM) has been reported by low endemicity countries in the European Region.
15 countries (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Slovenia, Spain, Sweden, and the United Kingdom) reported 1173 cases related to the 3 distinct multi-country hepatitis A outbreaks. Most of the affected countries have routinely recommended hepatitis A vaccine for MSM, but there is currently limited availability of this vaccine worldwide.
In Spain, hepatitis A cases reported in 2017 are almost 8 times higher than the average number of cases reported during the same period between the years 2012 and 2016. Most cases are men aged between 15 to 45 years old, and MSM are the most affected group.
For more information about preventing Hepatitis A outbreaks on the euro.who.int website
For the third year in row deaths from drugs overdose in Europe have increased, with the UK and Germany together accounting for around half of these deaths, according to the latest European Drug Report.
A total of 8,441 overdose deaths, mainly related to heroin and other opioids, are estimated to have occurred in Europe in 2015, a 6% increase on 2014. Increases were reported in almost all age groups and the UK accounted for 31% of the deaths, with Germany a distant second on 15%.
The report finds that the three European countries with the highest volume of drug online sales are Germany, the Netherlands and the United Kingdom, with stimulants, in particular MDMA and cocaine, accounting for most of the sales revenue.
For more information and to download the European Drug Report from the ec.europa.eu website
A recent survey shows no decrease in the overall smoking rate in the EU since 2014, with more than one in four Europeans still smoking. Amongst people aged 15 to 24 the rate has increased from 25% in 2014 to 29% in 2017.
Significant differences exist between EU countries, with the highest smoking rates in Greece (37%), Bulgaria, France (both 36%) and Croatia (35%). At 7%, Sweden has the lowest smoking rate in the EU. Regular e-cigarette use remains stable at 2%, with 15% having tried such products at some point. With regard to attitudes to tobacco and e-cigarette control measures, the majority of those surveyed (63%) think e-cigarette use should be banned in places where there are smoking bans; and 46% are in favour of plain packaging for cigarettes.
To read the full Eurobarometer on attitudes of Europeans to smoking and e-cigarettes on the ec.europa.eu website
This independent report, commissioned by WHO and written by Sir Liam Donaldson, reflects on the trends, achievements and challenges in global health over the past decade. It discusses the role of WHO in dealing with such issues as the rise of noncommunicable diseases, leaps in life expectancy, and emerging threats like climate change and antimicrobial resistance.
The sections include:
- Saving mothers and children
- Microbes: old and new
- The ascendancy of noncommunicable diseases
- Healthy ageing
To download the full report ‘Healthier, fairer, safer: the global health journey 2007–2017′ from the who.int website
The EU has produced new rules on medical devices to enhance patient safety and modernise public health.
There are over 500,000 types of medical devices and in-vitro diagnostic medical devices on the EU market. Examples of medical devices are contact lenses, x-ray machines, pacemakers, breast implants and hip replacements and sticking plasters. In vitro diagnostic medical devices, which are used to perform tests on samples, include HIV blood tests, pregnancy tests and blood sugar monitoring systems for diabetics.
The new Regulations will help to ensure that all medical devices – from heart valves to sticking plasters to artificial hips – are safe and perform well. The new rules will improve market surveillance and traceability as well as make sure that all medical and in vitro diagnostic devices are designed to reflect the latest scientific and technological state-of-the art. The rules will also provide more transparency and legal certainty for producers, manufacturers and importers and help to strengthen international competitiveness and innovation in this strategic sector.
For more information on the new rules about medical devices on the europa.eu website